Related Experiment Videos
Fetal surgery: correction of anatomic and constitutional defects
1Department of Surgery, University of Louisville School of Medicine, KY 40292.
The Journal of the Kentucky Medical Association
|May 1, 1992
Summary
Advances in prenatal diagnostics and obstetrical care enable fetal therapy for congenital defects. Research is expanding to include in utero stem cell and gene therapies, focusing on safety and efficacy for mother and child.
Area of Science:
- Perinatology
- Maternal-Fetal Medicine
- Pediatric Surgery
Background:
- Improved obstetrical care and advanced fetal diagnostics necessitate multidisciplinary management of pregnancies with congenital defects.
- Fetal therapy has evolved beyond Rh disease transfusions and lung maturation induction.
- Current fetal interventions include open correction for conditions like congenital hydronephrosis, diaphragmatic hernia, and sacrococcygeal teratoma.
Purpose of the Study:
- To review the expansion of fetal therapy for complex congenital anomalies.
- To highlight emerging in utero treatments such as hematopoietic stem cell transplantation and gene therapy.
- To emphasize the ongoing research focus on therapeutic efficacy and safety in fetal interventions.
Main Methods:
- Review of current literature on fetal diagnostic techniques and therapeutic interventions.
- Analysis of the evolution of fetal surgery and its expanding applications.
- Examination of ongoing research into novel prenatal treatments.
Main Results:
- Fetal therapy now encompasses surgical correction of major congenital anomalies.
- Investigational therapies include in utero hematopoietic stem cell transplantation and gene therapy.
- Research is actively exploring methods to enhance the effectiveness and safety of prenatal interventions.
Conclusions:
- Multidisciplinary care is crucial for managing pregnancies with prenatally diagnosed defects.
- The scope of fetal therapy has significantly broadened, offering new hope for complex conditions.
- Future research priorities include optimizing efficacy and ensuring maternal-fetal safety for advanced prenatal therapies.